4.5 Article

ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells

期刊

JOURNAL OF CELL SCIENCE
卷 123, 期 7, 页码 1171-1180

出版社

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/jcs.062034

关键词

ATAD3A; Lung adenocarcinoma; Mitochondrial fragmentation; Cisplatin sensitivity

资金

  1. NSC [NSC 97-3112-B-001-016]
  2. Comprehensive Academic Promotion Projects [NCHU 975014]

向作者/读者索取更多资源

AAA domain-containing 3A (ATAD3A) is a member of the AAA-ATPase family. Three forms of ATAD3 have been identified: ATAD3A, ATAD3B and ATAD3C. In this study, we examined the type and expression of ATAD3 in lung adenocarcinoma (LADC). Expression of ATAD3A was detected by reverse transcription-polymerase chain reaction, immunoblotting, immunohistochemistry and confocal immunofluorescent microscopy. Our results show that ATAD3A is the major form expressed in LADC. Silencing of ATAD3A expression increased mitochondrial fragmentation and cisplatin sensitivity. Serum deprivation increased ATAD3A expression and drug resistance. These results suggest that ATAD3A could be an anti-apoptotic marker in LADC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers

Shu-Fen Chiang, Chih-Yang Huang, Tao-Wei Ke, Tsung-Wei Chen, Yu-Ching Lan, Ying-Shu You, William Tzu-Liang Chen, K. S. Clifford Chao

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

Article Oncology

Prognostic relevance of programmed cell death-ligand 1 expression and CD8+TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy

Tsung-Wei Chen, Kevin Chih-Yang Huang, Shu-Fen Chiang, William Tzu-Liang Chen, Tao-Wei Ke, K. S. Clifford Chao

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)

Article Cell Biology

The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy

Chung-Hao Chen, Jing-Wei Lin, Chih-Yang Huang, Yu-Lan Yeh, Chia-Yao Shen, Khan Farheen Badrealam, Tsung-Jung Ho, V. Vijaya Padma, Wei-Wen Kuo

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Article Oncology

Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer

Kevin Chih-Yang Huang, Shu-Fen Chiang, William Tzu-Liang Chen, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Tao-Wei Ke, K. S. Clifford Chao

CANCERS (2020)

Article Multidisciplinary Sciences

Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy

Kevin Chih-Yang Huang, Shu-Fen Chiang, Tsung-Wei Chen, William Tzu-Liang Chen, Pei-Chen Yang, Tao-Wei Ke, K. S. Clifford Chao

SCIENTIFIC REPORTS (2020)

Article Oncology

Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer

Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, Tsung-Wei Chen, Tao-Wei Ke, K. S. Clifford Chao

Summary: Immunosurveillance and immunoscavenging induced by preoperative chemoradiotherapy (CCRT) can enhance local control and improve survival rates in locally advanced rectal cancer patients. This study focused on the impact of different genotypes of pattern recognition receptors (PRRs) on therapeutic efficacy in LARC patients receiving CCRT. The findings suggest that the FPR1 genotype may play a role in CCRT-induced anticancer immunity, affecting T lymphocyte migration and infiltration, and could serve as a biomarker for chemo- and radiotherapy outcomes.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Cell Biology

ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer

Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Chen-Yu Lin, Hsin-Yu Chang, William Tzu-Liang Chen, Kun-San Clifford Chao

Summary: ATAD3A overexpression is clinically associated with poor prognosis, especially in high-risk colorectal cancer patients receiving adjuvant chemotherapy. ATAD3A plays a crucial role in reducing chemotherapy-induced cancer cell death by interacting with GRP78 protein to alleviate ER stress. Pharmacologic targeting to ATAD3A may enhance antitumor immunity for CRC patients receiving adjuvant chemotherapy.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Oncology

Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy

Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Yi-Wen Huang, Hsin-Yu Chang, William Tzu-Liang Chen, K. S. Clifford Chao

Summary: The study evaluates the induction of immunogenic cell death (ICD) by the novel topoisomerase I inhibitor lipotecan for anticancer immunity. Lipotecan significantly increases tumor immunogenicity and promotes therapeutic efficacy of radiotherapy compared to conventional chemoradiotherapy in vivo. These results suggest potential therapeutic strategies to improve the efficacy of chemoradiotherapy in colorectal cancer patients, particularly those with locally advanced rectal cancer.

CANCERS (2021)

Article Multidisciplinary Sciences

Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response

Yu-Ting Yen, May Chien, Pei-Yi Wu, Chi-Chang Ho, Chun-Te Ho, Kevin Chih-Yang Huang, Shu-Fen Chiang, K. S. Clifford Chao, William Tzu-Liang Chen, Shih-Chieh Hung

Summary: This study demonstrates that inactivation of protein phosphatase 2A (PP2A) converts cold microsatellite-stable (MSS) tumors into microsatellite-instable (MSI) tumors, promoting cytotoxic T cell infiltration and response to immune checkpoint blockade (ICB).

NATURE COMMUNICATIONS (2021)

Article Oncology

Prognostic and clinical significance of subcellular CDC27 for patients with rectal adenocarcinoma treated with adjuvant chemotherapy

Chia-Lin Chang, Kevin Chih-Yang Huang, Tsung-Wei Chen, William Tzu-Liang Chen, Hsuan-Hua Huang, Ya-Ling Liu, Chia-Hui Kuo, K. S. Clifford Chao, Tao-Wei Ke, Shu-Fen Chiang

Summary: The expression of CDC27 is associated with the risk of metastasis in rectal adenocarcinoma patients, and nuclear CDC27 expression is negatively correlated with survival rates. High nuclear CDC27 expression is significantly associated with poorer treatment outcomes. Therefore, CDC27 expression may serve as a potential prognostic marker for tumor progression and chemotherapy treatment in rectal cancer.

ONCOLOGY LETTERS (2022)

Article Cell Biology

Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade

Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, William Tzu-Liang Chen, Pei-Chen Yang, Tsung-Wei Chen, Ji-An Liang, An-Cheng Shiau, Tao-Wei Ke, K. S. Clifford Chao

Summary: This study demonstrates that engineering mesenchymal stem cells (MSCs) to express specific anti-cancer genes can enhance the sensitivity of radiotherapy in colorectal cancer patients. This novel therapeutic strategy not only improves the effectiveness of radiotherapy, but also remodels the tumor microenvironment, making it more suitable for immunotherapy.

CELL DEATH & DISEASE (2022)

Article Oncology

Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1

Tsung-Wei Chen, Wei-Ze Hung, Shu-Fen Chiang, William Tzu-Liang Chen, Tao-Wei Ke, Ji-An Liang, Chih-Yang Huang, Pei-Chen Yang, Kevin Chih-Yang Huang, K. S. Clifford Chao

Summary: TGF-beta plays a role in chemoresistance in advanced colorectal cancer by regulating PD-L1 expression. TAMs and TUB are the main components that regulate PD-L1 expression within the immunosuppressive tumor microenvironment.

CANCER LETTERS (2022)

Article Multidisciplinary Sciences

Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer

Kevin Chih-Yang Huang, Tao-Wei Ke, Jia-Yi Chen, Wei-Ze Hong, Shu-Fen Chiang, Chia-Ying Lai, Tsung-Wei Chen, Pei-Chen Yang, Liang-Chi Chen, Ji-An Liang, William Tzu-Liang Chen, K. S. Clifford Chao

Summary: This study found that patients with colorectal cancer who carry the TLR1-N248S polymorphism may have a higher risk of distant metastasis and poorer response to adjuvant chemotherapy. Defective TLR1 affects dendritic cell maturation and immune cell infiltration, while TLR1/2 agonists enhance the efficacy of chemotherapy and increase tumor-infiltrating immune cells.

SCIENTIFIC REPORTS (2023)

Article Oncology

DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy

Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Hsin-Yu Chang, Ji-An Liang, William Tzu-Liang Chen, K. S. Clifford Chao

Summary: The study found a negative correlation between PD-L1 promoter methylation and tumor PD-L1 expression in locally advanced colorectal cancer patients, identifying it as an independent biomarker. PD-L1 methylation was associated with decreased disease-free survival and classified as an independent prognostic factor for poor 5-year DFS. The immunomodulatory agent DNMTi improved the efficacy of radiotherapy and anti-PD-L1 immunotherapy by inducing tumor PD-L1 expression and enhancing immune responses.

ONCOIMMUNOLOGY (2021)

Article Oncology

The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ)

Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, William Tzu-Liang Chen, Tsung-Wei Chen, Kun-San Clifford Chao

CANCER GENOMICS & PROTEOMICS (2020)

暂无数据